|
Q4 2017
Filed on Feb 14, 2018
|
1,051,177
|
$10.87 - $13.9
$11.4M - $14.6M
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
103,818
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
27,712
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
21,244
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
41,730
|
N/A
|
|
Ligand Pharmaceuticals Inc
|
Q4 2017
Filed on Feb 14, 2018
|
56,931
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
8,314
|
$21.39 - $25.8
$178K - $215K
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
61,725
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
63,049
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
105,937
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
23,995
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
20,373
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
18,379
|
N/A
|
|
Level 3 Communications Inc
|
Q4 2017
Filed on Feb 14, 2018
|
314,932
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
10,392
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
25,746
|
$24.12 - $29.79
$621K - $767K
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
51,163
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
194,096
|
N/A
|
|